Showing results (71-80 of 152) with videos related to

Sort By:
Pageof 16
Journal of Hepatology|November 6, 2021
EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging studyVlad Ratziu, Mary E Rinella, Brent A Neuschwander-Tetri, et al.
Viruses|October 28, 2023
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated CirrhosisSteven Flamm, Eric Lawitz, Brian Borg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2019
Adherence to pan-genotypic glecaprevir/pibrentasvir and efficacy in HCV-infected patients: A pooled analysis of clinical trialsAshley Brown, Tania M Welzel, Brian Conway, et al.
Antiviral Therapy|February 8, 2014
Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitorDavid Nelson, Eric M Yoshida, Matthew S Paulson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2015
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGEMaria Buti, Stuart C Gordon, Eli Zuckerman, et al.
Alimentary Pharmacology & Therapeutics|November 27, 2025
Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction-Associated SteatohepatitisJuan Frias, Robert Schmouder, Eric Lawitz, et al.
The Journal of Infectious Diseases|November 26, 2015
L159F and V321A Sofosbuvir-Associated Hepatitis C Virus NS5B SubstitutionsEvguenia S Svarovskaia, Edward Gane, Hadas Dvory-Sobol, et al.
JCI Insight|January 26, 2018
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitisRohit Loomba, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 15, 2013
Combination of vaniprevir with peginterferon and ribavirin significantly increases the rate of SVR in treatment-experienced patients with chronic HCV genotype 1 infection and cirrhosisMaribel Rodriguez-Torres, Albrecht Stoehr, Edward J Gane, et al.
Antiviral Therapy|November 16, 2022
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis BJordan J Feld, Eric Lawitz, Tuan Nguyen, et al.
Pageof 16